Last update 27 May 2025

MSC11FCD

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Stem cell replacements
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
GliosarcomaRecurrent Glioblastoma
Originator Organization
CHA University
Active Organization-
Inactive Organization
CHA University
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with MSC11FCD
KCT0010450
/ Not yet recruitingNot ApplicableIIT
Clinical Research of Suicide Gene Expressing Allogenic Bone Marrow Derived Mesenchymal Stem Cells(MSC11FCD) in Patients with Newly Diagnosed Glioblastoma
KCT0005886
/ RecruitingPhase 1/2IIT
Investigator-initiated and open-labeled clinical trial for evaluation of maximum tolerented dose, safety and efficiency of MSC11FCD therapy to recurrent glioblastoma patients
NCT04657315
/ CompletedPhase 1/2IIT
Investigator-initiated and Open-labeled Clinical Trial for Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
100 Clinical Results associated with MSC11FCD
Login to view more data
100 Translational Medicine associated with MSC11FCD
Login to view more data
100 Patents (Medical) associated with MSC11FCD
Login to view more data
100 Deals associated with MSC11FCD
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GliosarcomaPhase 2
United States
CHA University
24 Jun 2020
Recurrent GlioblastomaPhase 2
United States
CHA University
24 Jun 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free